Subcellular localization of proteasomes and their regulatory complexes in mammalian cells

Biochem J. 2000 Feb 15;346 Pt 1(Pt 1):155-61.

Abstract

Proteasomes can exist in several different molecular forms in mammalian cells. The core 20S proteasome, containing the proteolytic sites, binds regulatory complexes at the ends of its cylindrical structure. Together with two 19S ATPase regulatory complexes it forms the 26S proteasome, which is involved in ubiquitin-dependent proteolysis. The 20S proteasome can also bind 11S regulatory complexes (REG, PA28) which play a role in antigen processing, as do the three variable gamma-interferon-inducible catalytic beta-subunits (e.g. LMP7). In the present study, we have investigated the subcellular distribution of the different forms of proteasomes using subunit specific antibodies. Both 20S proteasomes and their 19S regulatory complexes are found in nuclear, cytosolic and microsomal preparations isolated from rat liver. LMP7 was enriched approximately two-fold compared with core alpha-type proteasome subunits in the microsomal preparations. 20S proteasomes were more abundant than 26S proteasomes, both in liver and cultured cell lines. Interestingly, some significant differences were observed in the distribution of different subunits of the 19S regulatory complexes. S12, and to a lesser extent p45, were found to be relatively enriched in nuclear fractions from rat liver, and immunofluorescent labelling of cultured cells with anti-p45 antibodies showed stronger labelling in the nucleus than in the cytoplasm. The REG was found to be localized predominantly in the cytoplasm. Three- to six-fold increases in the level of REG were observed following gamma-interferon treatment of cultured cells but gamma-interferon had no obvious effect on its subcellular distribution. These results demonstrate that different regulatory complexes and subpopulations of proteasomes have different distributions within mammalian cells and, therefore, that the distribution is more complex than has been reported for yeast proteasomes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphate / pharmacology
  • Animals
  • Antibodies, Monoclonal / immunology
  • Biological Transport / drug effects
  • Blotting, Western
  • Cell Line
  • Cell Nucleus / drug effects
  • Cell Nucleus / enzymology
  • Cysteine Endopeptidases / analysis*
  • Cysteine Endopeptidases / chemistry*
  • Cysteine Endopeptidases / immunology
  • Cysteine Endopeptidases / metabolism
  • Cytosol / drug effects
  • Cytosol / enzymology
  • Endoplasmic Reticulum / drug effects
  • Endoplasmic Reticulum / enzymology
  • Endoplasmic Reticulum / metabolism
  • Enzyme Stability / drug effects
  • Fluorescent Antibody Technique
  • Humans
  • Interferon-gamma / pharmacology
  • Liver / cytology
  • Liver / drug effects
  • Liver / enzymology
  • Microsomes, Liver / drug effects
  • Microsomes, Liver / enzymology
  • Molecular Weight
  • Multienzyme Complexes / analysis*
  • Multienzyme Complexes / chemistry*
  • Multienzyme Complexes / immunology
  • Multienzyme Complexes / metabolism
  • Peptide Hydrolases / analysis
  • Peptide Hydrolases / chemistry
  • Peptide Hydrolases / immunology
  • Peptide Hydrolases / metabolism
  • Proteasome Endopeptidase Complex
  • Rats

Substances

  • Antibodies, Monoclonal
  • Multienzyme Complexes
  • Interferon-gamma
  • Adenosine Triphosphate
  • Peptide Hydrolases
  • Cysteine Endopeptidases
  • Proteasome Endopeptidase Complex
  • ATP dependent 26S protease